ARIMIDEX
Total Payments
$36,300
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $36,300 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $36,300 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Dose Response Relationships between Gonadal Steroids and Bone Turnover in Men | AstraZeneca Pharmaceuticals LP | $36,300 | 0 |
Top Doctors Receiving Payments for ARIMIDEX
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $36,300 | 1 |
Ad
Manufacturing Companies
- AstraZeneca Pharmaceuticals LP $36,300
Product Information
- Type Drug
- Total Payments $36,300
- Total Doctors 0
- Transactions 1
About ARIMIDEX
ARIMIDEX is a drug associated with $36,300 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is AstraZeneca Pharmaceuticals LP.
Payment data is available from 2017 to 2017. In 2017, $36,300 was paid across 1 transactions to 0 doctors.
The most common payment nature for ARIMIDEX is "Unspecified" ($36,300, 100.0% of total).
ARIMIDEX is associated with 1 research study, including "Dose Response Relationships between Gonadal Steroids and Bone Turnover in Men" ($36,300).